Stock RVTY REVVITY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Revvity, Inc.

Equities

RVTY

US7140461093

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-23 pm EDT 		5-day change 1st Jan Change
103.5 USD +2.71% Intraday chart for Revvity, Inc. +3.21% -5.32%
Apr. 22 Bernstein Adjusts Price Target on Revvity to $125 From $126 MT
Apr. 22 Baird Adjusts Price Target on Revvity to $126 From $123 MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Bernstein Adjusts Price Target on Revvity to $125 From $126
MT
Baird Adjusts Price Target on Revvity to $126 From $123
MT
Ex-dividend day
FA
Revvity Signals Software's New Synergy Solution Redefines Collaboration between Pharma and Contract Partners
AQ
Revvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners
BU
Revvity To Hold Earnings Call on Monday, April 29, 2024
BU
Preliminary Injunction Granted to Enforce Revvity s Rights and Cloud Software Group s Obligations Related to Spotfire Software
AQ
Revvity Says Court Issued Preliminary Injunction Against Cloud Software Group
MT
Revvity Says Court Issued Preliminary Injunction Against Cloud Software Group
MT
Preliminary Injunction Granted to Enforce Revvity’s Rights and Cloud Software Group’s Obligations Related to Spotfire Software
BU
Revvity Files Lawsuit Against Partner Cloud Software Group, Reaffirms 2024 Guidance
MT
Revvity Files Complaint and Seeks Injunctive Relief Against Cloud Software Group
BU
Revvity, Inc. Re-Affirms Earnings Guidance for the Full Year 2024
CI
Transcript : Revvity, Inc. Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-20-2024 09:00 AM
Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication
BU
Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication
CI
Revvity, Inc. Introduces New Workflow to Accelerate Newborn Sequencing Research
CI
Revvity : Notice of Annual Meeting and Proxy Statement 2024
PU
Revvity Inc Receives a Shareholder Proposal from John Chevedden
CI
Transcript : Revvity, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 09:30 AM
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RVTY Stock
  4. News Revvity, Inc.